Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Yu Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2819-4551; OpenAlex author ID A5017624626. Sources: OpenAlex.

Their work

Papers
7 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers

Papers 7

  1. Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes. First author DOI 10.1007/s00262-022-03269-3↗
  2. Correction to: Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes. First author DOI 10.1007/s00262-022-03296-0↗
  3. Characterization of DNA damage response deficiency in pancreatic cancer patients from China. Co-author DOI 10.1002/cac2.12238↗
  4. Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma. First author DOI 10.1016/j.phrs.2020.105370↗
  5. Development and clinical validation of A Novel 9-gene prognostic biomarkers based on multi-omics in pancreatic adenocarcinoma First author DOI 10.21203/rs.3.rs-49603/v1↗
  6. Prognostic value and clinicopathological features of PD-1/PD-L1 expression with mismatch repair status and desmoplastic stroma in Chinese patients with pancrea… Co-author DOI 10.18632/oncotarget.14069↗
  7. Allogeneic cell-based immunotherapy combined with chemotherapy and targeted therapy in advanced pancreatic cancer with metastases: A case report. Co-author DOI 10.3892/ol.2014.1908↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dafeng Xu · 4 shared papers, 2020–2023 · strength 0.78
  2. Jinfang Zheng · 3 shared papers, 2021–2023 · strength 0.66
  3. Feng Jiao · 2 shared papers, 2017–2022 · strength 0.19
  4. Jiujie Cui · 2 shared papers, 2017–2022 · strength 0.19
  5. Jinfang Zheng · 1 shared paper, 2020 · strength 0.11
  6. Yingbin Liu · 1 shared paper, 2022 · strength 0.11
  7. Xiaofei Zhang · 1 shared paper, 2022 · strength 0.11
  8. Tiebo Mao · 1 shared paper, 2022 · strength 0.11
  9. Qiang Liu · 1 shared paper, 2022 · strength 0.11
  10. Jiong Hu · 1 shared paper, 2022 · strength 0.11
  11. Yongwei Sun · 1 shared paper, 2022 · strength 0.11
  12. Liwei Wang · 1 shared paper, 2022 · strength 0.11
  13. Jiayu Yao · 1 shared paper, 2022 · strength 0.11
  14. Shumin Li · 1 shared paper, 2022 · strength 0.11
  15. Yuexiang Wang · 1 shared paper, 2022 · strength 0.11
  16. Deliang Fu · 1 shared paper, 2022 · strength 0.11
  17. Meng Zhuo · 1 shared paper, 2017 · strength 0.08
  18. Ting Han · 1 shared paper, 2017 · strength 0.08
  19. Liwei Wang · 1 shared paper, 2017 · strength 0.08
  20. Yanyan Long · 1 shared paper, 2014 · strength 0.06
  21. Shunchang Jiao · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.